{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T10:34:23Z","timestamp":1773484463036,"version":"3.50.1"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,30]]},"DOI":"10.7759\/cureus.33146","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T19:14:01Z","timestamp":1672427641000},"source":"Crossref","is-referenced-by-count":8,"title":["Group A Streptococcus Infections: Their Mechanisms, Epidemiology, and Current Scope of Vaccines"],"prefix":"10.7759","author":[{"given":"Vinayak","family":"Iyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devinder","family":"Toor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valarie","family":"Lyngdoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Nongrum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Chakraborti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-3368","article-title":"Burden of acute sore throat and group A streptococcal pharyngitis in school-aged children and their families in Australia","volume":"120","author":"Danchin MH","year":"2007","unstructured":"Danchin MH, Rogers S, Kelpie L, et al.. Burden of acute sore throat and group A streptococcal pharyngitis in school-aged children and their families in Australia. Pediatrics. 2007, 120:950-7. 10.1542\/peds.2006-3368","journal-title":"Pediatrics"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis JR","year":"2005","unstructured":"Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005, 5:685-94. 10.1016\/S1473-3099(05)70267-X","journal-title":"Lancet Infect Dis"},{"key":"ref3","article-title":"History of streptococcal research","author":"Ferretti J","year":"2016","unstructured":"Ferretti J, K\u00f6hler W. History of streptococcal research. Streptococcus Pyogenes: Basic Biology to Clinical Manifestations [Internet]. University of Oklahoma Health Sciences Center, Oklahoma; 2016."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1517_16","article-title":"Antimicrobial resistance in beta-haemolytic streptococci in India: a four-year study","volume":"147","author":"Bhardwaj N","year":"2018","unstructured":"Bhardwaj N, Mathur P, Behera B, Mathur K, Kapil A, Misra MC. Antimicrobial resistance in beta-haemolytic streptococci in India: a four-year study. Indian J Med Res. 2018, 147:81-7. 10.4103\/ijmr.IJMR_1517_16","journal-title":"Indian J Med Res"},{"key":"ref5","article-title":"Jai Vigyan Mission mode project on community control of RHD","volume":"8","author":"ICMR","year":"2007","unstructured":"ICMR. Jai Vigyan Mission mode project on community control of RHD. Indian Council Med Res Annu Rep. 2007, 8:63-4.","journal-title":"Indian Council Med Res Annu Rep"},{"key":"ref6","article-title":"Ananthanarayan and Paniker's Textbook of Microbiology","author":"Ananthanarayan R","year":"2006","unstructured":"Ananthanarayan R. Ananthanarayan and Paniker's Textbook of Microbiology. Orient Blackswan, Hyderabad; 2006."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.2.3.285","article-title":"Streptococcal M protein: molecular design and biological behavior","volume":"2","author":"Fischetti VA","year":"1989","unstructured":"Fischetti VA. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev. 1989, 2:285-314. 10.1128\/CMR.2.3.285","journal-title":"Clin Microbiol Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2010.02.007","article-title":"The streptococcal M protein: a highly versatile molecule","volume":"18","author":"Smeesters PR","year":"2010","unstructured":"Smeesters PR, McMillan DJ, Sriprakash KS. The streptococcal M protein: a highly versatile molecule. Trends Microbiol. 2010, 18:275-82. 10.1016\/j.tim.2010.02.007","journal-title":"Trends Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu260","article-title":"A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development","volume":"210","author":"Sanderson-Smith M","year":"2014","unstructured":"Sanderson-Smith M, De Oliveira DM, Guglielmini J, et al.. A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. J Infect Dis. 2014, 210:1325-38. 10.1093\/infdis\/jiu260","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000010","article-title":"Differences between Belgian and Brazilian group A streptococcus epidemiologic landscape","volume":"1","author":"Smeesters PR","year":"2006","unstructured":"Smeesters PR, Vergison A, Campos D, de Aguiar E, Miendje Deyi VY, Van Melderen L. Differences between Belgian and Brazilian group A streptococcus epidemiologic landscape. PLoS One. 2006, 1:e10. 10.1371\/journal.pone.0000010","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7030058","article-title":"Recent advances in the development of peptide vaccines and their delivery systems against group A streptococcus","volume":"7","author":"Azuar A","year":"2019","unstructured":"Azuar A, Jin W, Mukaida S, Hussein WM, Toth I, Skwarczynski M. Recent advances in the development of peptide vaccines and their delivery systems against group A streptococcus. Vaccines (Basel). 2019, 7:58. 10.3390\/vaccines7030058","journal-title":"Vaccines (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001018","article-title":"Decoding the molecular epidemiology of group A streptococcus: an Indian perspective","volume":"68","author":"Abraham T","year":"2019","unstructured":"Abraham T, Sistla S. Decoding the molecular epidemiology of group A streptococcus: an Indian perspective. J Med Microbiol. 2019, 68:1059-71. 10.1099\/jmm.0.001018","journal-title":"J Med Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.3.470","article-title":"Pathogenesis of group A streptococcal infections","volume":"13","author":"Cunningham MW","year":"2000","unstructured":"Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000, 13:470-511. 10.1128\/CMR.13.3.470","journal-title":"Clin Microbiol Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.57.4.571","article-title":"A serological differentiation of human and other groups of hemolytic streptococci","volume":"57","author":"Lancefield RC","year":"1933","unstructured":"Lancefield RC.  A serological differentiation of human and other groups of hemolytic streptococci. J Exp Med. 1933, 57:571-95. 10.1084\/jem.57.4.571","journal-title":"J Exp Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.161.6.1384","article-title":"Size variation of the M protein in group A streptococci","volume":"161","author":"Fischetti VA","year":"1985","unstructured":"Fischetti VA, Jones KF, Scott JR. Size variation of the M protein in group A streptococci. J Exp Med. 1985, 161:1384-401. 10.1084\/jem.161.6.1384","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4161\/viru.2.5.16342","article-title":"The M protein of group A streptococcus is a key virulence factor and a clinically relevant strain identification marker","volume":"2","author":"Metzgar D","year":"2011","unstructured":"Metzgar D, Zampolli A. The M protein of group A streptococcus is a key virulence factor and a clinically relevant strain identification marker. Virulence. 2011, 2:402-12. 10.4161\/viru.2.5.16342","journal-title":"Virulence"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196409242711301","article-title":"Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever: association with cardiac failure","volume":"271","author":"Kaplan MH","year":"1964","unstructured":"Kaplan MH, Bolande R, Rakita L, Blair J. Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever: association with cardiac failure. N Engl J Med. 1964, 271:637-45. 10.1056\/NEJM196409242711301","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1993.1106","article-title":"Alpha-helical coiled-coil molecules: a role in autoimmunity against the heart","volume":"68","author":"Cunningham MW","year":"1993","unstructured":"Cunningham MW, Antone SM, Gulizia JM, McManus BA, Gauntt CJ. Alpha-helical coiled-coil molecules: a role in autoimmunity against the heart. Clin Immunol Immunopathol. 1993, 68:118-23. 10.1006\/clin.1993.1106","journal-title":"Clin Immunol Immunopathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.9.3913-3923.1997","article-title":"Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein","volume":"65","author":"Cunningham MW","year":"1997","unstructured":"Cunningham MW, Antone SM, Smart M, Liu R, Kosanke S. Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein. Infect Immun. 1997, 65:3913-23. 10.1128\/iai.65.9.3913-3923.1997","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/9780470015902.a0005126.pub2","article-title":"Gene families: multigene families and superfamilies","author":"Ohta T","year":"2001","unstructured":"Ohta T. Gene families: multigene families and superfamilies. Encyclopedia of Life Sciences. Wiley, New York; 2001. 30. 10.1002\/9780470015902.a0005126.pub2"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.63.1.174-229.1999","article-title":"Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope","volume":"63","author":"Navarre WW","year":"1999","unstructured":"Navarre WW, Schneewind O. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev. 1999, 63:174-229. 10.1128\/MMBR.63.1.174-229.1999","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2007.06006.x","article-title":"The Mga virulence regulon: infection where the grass is greener","volume":"66","author":"Hondorp ER","year":"2007","unstructured":"Hondorp ER, McIver KS. The Mga virulence regulon: infection where the grass is greener. Mol Microbiol. 2007, 66:1056-65. 10.1111\/j.1365-2958.2007.06006.x","journal-title":"Mol Microbiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-1097(97)00139-0","article-title":"M protein mediated adhesion of M type 24 Streptococcus pyogenes stimulates release of interleukin-6 by HEp-2 tissue culture cells","volume":"151","author":"Courtney HS","year":"1997","unstructured":"Courtney HS, Ofek I, Hasty DL. M protein mediated adhesion of M type 24 Streptococcus pyogenes stimulates release of interleukin-6 by HEp-2 tissue culture cells. FEMS Microbiol Lett. 1997, 151:65-70. 10.1016\/s0378-1097(97)00139-0","journal-title":"FEMS Microbiol Lett"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/07853890252953464","article-title":"Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci","volume":"34","author":"Courtney HS","year":"2002","unstructured":"Courtney HS, Hasty DL, Dale JB. Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci. Ann Med. 2002, 34:77-87. 10.1080\/07853890252953464","journal-title":"Ann Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/82_2012_281","article-title":"Adherence and invasion of streptococci to eukaryotic cells and their role in disease pathogenesis","author":"Rohde M","year":"2013","unstructured":"Rohde M, Chhatwal GS. Adherence and invasion of streptococci to eukaryotic cells and their role in disease pathogenesis. Host-Pathogen Interactions in Streptococcal Diseases, Current Topics in Microbiology and Immunology. Springer, Berlin, Heidelberg; 2013. 83-110. 10.1007\/82_2012_281"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2217\/17460913.2.1.75","article-title":"How group A streptococcus circumvents host phagocyte defenses","volume":"2","author":"Kwinn LA","year":"2007","unstructured":"Kwinn LA, Nizet V. How group A streptococcus circumvents host phagocyte defenses. Future Microbiol. 2007, 2:75-84. 10.2217\/17460913.2.1.75","journal-title":"Future Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.1.40-48.2006","article-title":"Role of hyaluronidase in subcutaneous spread and growth of group A streptococcus","volume":"74","author":"Starr CR","year":"2006","unstructured":"Starr CR, Engleberg NC. Role of hyaluronidase in subcutaneous spread and growth of group A streptococcus. Infect Immun. 2006, 74:40-8. 10.1128\/IAI.74.1.40-48.2006","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.602847","article-title":"Mutual exclusivity of hyaluronan and hyaluronidase in invasive group A streptococcus","volume":"289","author":"Henningham A","year":"2014","unstructured":"Henningham A, Yamaguchi M, Aziz RK, et al.. Mutual exclusivity of hyaluronan and hyaluronidase in invasive group A streptococcus. J Biol Chem. 2014, 289:32303-15. 10.1074\/jbc.M114.602847","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.11.3557","article-title":"Streptokinase: cloning, expression, and excretion by Escherichia coli","volume":"81","author":"Malke H","year":"1984","unstructured":"Malke H, Ferretti JJ. Streptokinase: cloning, expression, and excretion by Escherichia coli. Proc Natl Acad Sci U S A. 1984, 81:3557-61. 10.1073\/pnas.81.11.3557","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1989.tb01808.x","article-title":"The streptokinase gene of group A streptococci: cloning, expression in Escherichia coli, and sequence analysis","volume":"3","author":"Huang TT","year":"1989","unstructured":"Huang TT, Malke H, Ferretti JJ. The streptokinase gene of group A streptococci: cloning, expression in Escherichia coli, and sequence analysis. Mol Microbiol. 1989, 3:197-205. 10.1111\/j.1365-2958.1989.tb01808.x","journal-title":"Mol Microbiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2648","article-title":"Molecular insight into invasive group A streptococcal disease","volume":"9","author":"Cole JN","year":"2011","unstructured":"Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol. 2011, 9:724-36. 10.1038\/nrmicro2648","journal-title":"Nat Rev Microbiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2005.05.006","article-title":"Is plasminogen deployed as a Streptococcus pyogenes virulence factor?","volume":"13","author":"Walker MJ","year":"2005","unstructured":"Walker MJ, McArthur JD, McKay F, Ranson M. Is plasminogen deployed as a Streptococcus pyogenes virulence factor?. Trends Microbiol. 2005, 13:308-13. 10.1016\/j.tim.2005.05.006","journal-title":"Trends Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2013.00085","article-title":"Interaction of streptococcal plasminogen binding proteins with the host fibrinolytic system","volume":"3","author":"Fulde M","year":"2013","unstructured":"Fulde M, Steinert M, Bergmann S. Interaction of streptococcal plasminogen binding proteins with the host fibrinolytic system. Front Cell Infect Microbiol. 2013, 3:85. 10.3389\/fcimb.2013.00085","journal-title":"Front Cell Infect Microbiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.202671","article-title":"Streptococcus pyogenes M49 plasminogen\/plasmin binding facilitates keratinocyte invasion via integrin-integrin-linked kinase (ILK) pathways and protects from macrophage killing","volume":"286","author":"Siemens N","year":"2011","unstructured":"Siemens N, Patenge N, Otto J, Fiedler T, Kreikemeyer B. Streptococcus pyogenes M49 plasminogen\/plasmin binding facilitates keratinocyte invasion via integrin-integrin-linked kinase (ILK) pathways and protects from macrophage killing. J Biol Chem. 2011, 286:21612-22. 10.1074\/jbc.M110.202671","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.323287","article-title":"Plasminogen is a complement inhibitor","volume":"287","author":"Barthel D","year":"2012","unstructured":"Barthel D, Schindler S, Zipfel PF. Plasminogen is a complement inhibitor. J Biol Chem. 2012, 287:18831-42. 10.1074\/jbc.M111.323287","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006493","article-title":"Multi-functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase","volume":"13","author":"Lynskey NN","year":"2017","unstructured":"Lynskey NN, Reglinski M, Calay D, Siggins MK, Mason JC, Botto M, Sriskandan S. Multi-functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase. PLoS Pathog. 2017, 13:e1006493. 10.1371\/journal.ppat.1006493","journal-title":"PLoS Pathog"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.523761","article-title":"Structural model for covalent adhesion of the Streptococcus pyogenes pilus through a thioester bond","volume":"289","author":"Linke-Winnebeck C","year":"2014","unstructured":"Linke-Winnebeck C, Paterson NG, Young PG, Middleditch MJ, Greenwood DR, Witte G, Baker EN. Structural model for covalent adhesion of the Streptococcus pyogenes pilus through a thioester bond. J Biol Chem. 2014, 289:177-89. 10.1074\/jbc.M113.523761","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/mmi.13556","article-title":"The group A streptococcus serotype M 2 pilus plays a role in host cell adhesion and immune evasion","volume":"103","author":"Tsai JC","year":"2017","unstructured":"Tsai JC, Loh JM, Clow F, Lorenz N, Proft T. The group A streptococcus serotype M 2 pilus plays a role in host cell adhesion and immune evasion. Mol Microbiol. 2017, 103:282-98. 10.1111\/mmi.13556","journal-title":"Mol Microbiol"},{"key":"ref39","article-title":"The Current Evidence for the Burden of Group A Streptococcal Diseases","author":"World Health Organization","year":"2005","unstructured":"World Health Organization. The Current Evidence for the Burden of Group A Streptococcal Diseases. World Health Organization, Geneva, Switzerland; 2005."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842x.1999.tb01227.x","article-title":"Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in aboriginal people","volume":"23","author":"Carapetis JR","year":"1999","unstructured":"Carapetis JR, Currie BJ. Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in aboriginal people. Aust N Z J Public Health. 1999, 23:159-63. 10.1111\/j.1467-842x.1999.tb01227.x","journal-title":"Aust N Z J Public Health"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1177\/101053959200600403","article-title":"Prevalence of cardiovascular diseases in rural area of Hmawbi and urban Yangon city","volume":"6","author":"Aung","year":"1992","unstructured":"Aung, Htoon MT, Ngwe T, Tun N, Kyaw MM. Prevalence of cardiovascular diseases in rural area of Hmawbi and urban Yangon city. Asia Pac J Public Health. 1992, 6:188-94. 10.1177\/101053959200600403","journal-title":"Asia Pac J Public Health"},{"key":"ref42","article-title":"Prevalence of rheumatic and congenital heart disease in schoolchildren of Kathmandu valley in Nepal","volume":"55","author":"Bahadur KM","year":"2002","unstructured":"Bahadur KM, Sharma D, Shrestha MP, et al.. Prevalence of rheumatic and congenital heart disease in schoolchildren of Kathmandu valley in Nepal. Indian Heart J. 2002, 55:615-8.","journal-title":"Indian Heart J"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-019-0677-6","article-title":"Impact of socio-economic factors on increased risk and progression of rheumatic heart disease in developing nations","volume":"21","author":"Sharma N","year":"2019","unstructured":"Sharma N, Toor D. Impact of socio-economic factors on increased risk and progression of rheumatic heart disease in developing nations. Curr Infect Dis Rep. 2019, 21:21. 10.1007\/s11908-019-0677-6","journal-title":"Curr Infect Dis Rep"},{"key":"ref44","unstructured":"Group A streptococcal disease. (2020). Accessed. June 30, 2020: https:\/\/www.cdc.gov\/groupastrep\/surveillance.html."},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy177","article-title":"Increasing rates of invasive group A streptococcal disease in Alberta, Canada; 2003-2017","volume":"5","author":"Tyrrell GJ","year":"2018","unstructured":"Tyrrell GJ, Fathima S, Kakulphimp J, Bell C. Increasing rates of invasive group A streptococcal disease in Alberta, Canada; 2003-2017. Open Forum Infect Dis. 2018, 5:ofy177. 10.1093\/ofid\/ofy177","journal-title":"Open Forum Infect Dis"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70178-1","article-title":"Global emm type distribution of group A streptococci: systematic review and implications for vaccine development","volume":"9","author":"Steer AC","year":"2009","unstructured":"Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis. 2009, 9:611-6. 10.1016\/S1473-3099(09)70178-1","journal-title":"Lancet Infect Dis"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00059","article-title":"Prevalent emm types among invasive GAS in Europe and North America since year 2000","volume":"6","author":"Gherardi G","year":"2018","unstructured":"Gherardi G, Vitali LA, Creti R. Prevalent emm types among invasive GAS in Europe and North America since year 2000. Front Public Health. 2018, 6:59. 10.3389\/fpubh.2018.00059","journal-title":"Front Public Health"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw243","article-title":"High incidence of invasive group A streptococcal infections in remote indigenous communities in Northwestern Ontario, Canada","volume":"4","author":"Bocking N","year":"2017","unstructured":"Bocking N, Matsumoto CL, Loewen K, et al.. High incidence of invasive group A streptococcal infections in remote indigenous communities in Northwestern Ontario, Canada. Open Forum Infect Dis. 2017, 4:ofw243. 10.1093\/ofid\/ofw243","journal-title":"Open Forum Infect Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.02.005","article-title":"Distribution of emm types and macrolide resistance determinants among group A streptococci in the Middle East and North Africa region","volume":"22","author":"Rafei R","year":"2020","unstructured":"Rafei R, Hawli M, Osman M, Dabboussi F, Hamze M. Distribution of emm types and macrolide resistance determinants among group A streptococci in the Middle East and North Africa region. J Global Antimicrob Resist. 2020, 22:334-48. 10.1016\/j.jgar.2020.02.005","journal-title":"J Global Antimicrob Resist"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00421-19","article-title":"Molecular epidemiology of noninvasive and invasive group A streptococcal infections in Cape Town","volume":"4","author":"Barth DD","year":"2019","unstructured":"Barth DD, Naicker P, Engel K, et al.. Molecular epidemiology of noninvasive and invasive group A streptococcal infections in Cape Town. Msphere. 2019, 4:e00421-19. 10.1128\/mSphere.00421-19","journal-title":"Msphere"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3201\/eid1502.080558","article-title":"Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007","volume":"15","author":"Steer AC","year":"2009","unstructured":"Steer AC, Jenney A, Kado J, et al.. Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007. Emerg Infect Dis. 2009, 15:216-22. 10.3201\/eid1502.080558","journal-title":"Emerg Infect Dis"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-8085-2","article-title":"Invasive group A streptococcus disease in Australian children: 2016 to 2018: a descriptive cohort study","volume":"19","author":"Oliver J","year":"2019","unstructured":"Oliver J, Thielemans E, McMinn A, et al.. Invasive group A streptococcus disease in Australian children: 2016 to 2018: a descriptive cohort study. BMC Public Health. 2019, 19:1750. 10.1186\/s12889-019-8085-2","journal-title":"BMC Public Health"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00312-09","article-title":"emm and C-repeat region molecular typing of beta-hemolytic streptococci in a tropical country: implications for vaccine development","volume":"47","author":"Steer AC","year":"2009","unstructured":"Steer AC, Magor G, Jenney AW, et al.. emm and C-repeat region molecular typing of beta-hemolytic streptococci in a tropical country: implications for vaccine development. J Clin Microbiol. 2009, 47:2502-9. 10.1128\/JCM.00312-09","journal-title":"J Clin Microbiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1086\/599344","article-title":"Seven-year surveillance of North American pediatric group A streptococcal pharyngitis isolates","volume":"49","author":"Shulman ST","year":"2009","unstructured":"Shulman ST, Tanz RR, Dale JB, et al.. Seven-year surveillance of North American pediatric group A streptococcal pharyngitis isolates. Clin Infect Dis. 2009, 49:78-84. 10.1086\/599344","journal-title":"Clin Infect Dis"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.4103\/ijmm.IJMM_17_16","article-title":"Molecular biology of group A streptococcus and its implications in vaccine strategies","volume":"35","author":"Brahmadathan NK","year":"2017","unstructured":"Brahmadathan NK. Molecular biology of group A streptococcus and its implications in vaccine strategies. Indian J Med Microbiol. 2017, 35:176-83. 10.4103\/ijmm.IJMM_17_16","journal-title":"Indian J Med Microbiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0178-8","article-title":"Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis","volume":"16","author":"Satoskar AA","year":"2020","unstructured":"Satoskar AA, Parikh SV, Nadasdy T. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol. 2020, 16:32-50. 10.1038\/s41581-019-0178-8","journal-title":"Nat Rev Nephrol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2018.12.007","article-title":"Current status of rheumatic heart disease in India","volume":"71","author":"Negi PC","year":"2019","unstructured":"Negi PC, Sondhi S, Asotra S, Mahajan K, Mehta A. Current status of rheumatic heart disease in India. Indian Heart J. 2019, 71:85-90. 10.1016\/j.ihj.2018.12.007","journal-title":"Indian Heart J"},{"key":"ref58","article-title":"Group A streptococcus virulence factors genes in north India and their association with emm type in pharyngitis","volume":"133","author":"Dhanda V","year":"2011","unstructured":"Dhanda V, Vohra H, Kumar R. Group A streptococcus virulence factors genes in north India and their association with emm type in pharyngitis. Indian J Med Res. 2011, 133:110-5.","journal-title":"Indian J Med Res"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.187116","article-title":"M types and toxin gene profile of group A streptococci isolated from children in Dibrugarh district of Assam, India","volume":"143","author":"Devi U","year":"2016","unstructured":"Devi U, Borah PK, Malik V, Parida P, Mahanta J. M types and toxin gene profile of group A streptococci isolated from children in Dibrugarh district of Assam, India. Indian J Med Res. 2016, 143:659-62. 10.4103\/0971-5916.187116","journal-title":"Indian J Med Res"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-2079-9","article-title":"Molecular characterization and evaluation of the emerging antibiotic-resistant Streptococcus pyogenes from eastern India","volume":"16","author":"Ray D","year":"2016","unstructured":"Ray D, Saha S, Sinha S, Pal NK, Bhattacharya B. Molecular characterization and evaluation of the emerging antibiotic-resistant Streptococcus pyogenes from eastern India. BMC Infect Dis. 2016, 16:753. 10.1186\/s12879-016-2079-9","journal-title":"BMC Infect Dis"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2013.06.018","article-title":"Comparative analysis of emm types, superantigen gene profiles and antibiotic resistance genes among Streptococcus pyogenes isolates from ocular infections, pharyngitis and asymptomatic children in south India","volume":"19","author":"Balaji K","year":"2013","unstructured":"Balaji K, Thenmozhi R, Prajna L, Dhananjeyan G, Pandian SK. Comparative analysis of emm types, superantigen gene profiles and antibiotic resistance genes among Streptococcus pyogenes isolates from ocular infections, pharyngitis and asymptomatic children in south India. Infect Genet Evol. 2013, 19:105-12. 10.1016\/j.meegid.2013.06.018","journal-title":"Infect Genet Evol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.06697-11","article-title":"Clinical and microbiologic characteristics of invasive Streptococcus pyogenes infections in north and south India","volume":"50","author":"Haggar A","year":"2012","unstructured":"Haggar A, Nerlich A, Kumar R, et al.. Clinical and microbiologic characteristics of invasive Streptococcus pyogenes infections in north and south India. J Clin Microbiol. 2012, 50:1626-31. 10.1128\/JCM.06697-11","journal-title":"J Clin Microbiol"},{"key":"ref63","article-title":"EMM types of Streptococcus pyogenes in Chennai","volume":"19","author":"Menon T","year":"2001","unstructured":"Menon T, Whatmore AM, Srivani S, Kumar MP, Anbumani N, Rajaji S. EMM types of Streptococcus pyogenes in Chennai. Indian J Med Microbiol. 2001, 19:161-2.","journal-title":"Indian J Med Microbiol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1086\/426443","article-title":"High diversity of group A streptococcal emm types in an Indian community: the need to tailor multivalent vaccines","volume":"40","author":"Dey N","year":"2005","unstructured":"Dey N, McMillan DJ, Yarwood PJ, et al.. High diversity of group A streptococcal emm types in an Indian community: the need to tailor multivalent vaccines. Clin Infect Dis. 2005, 40:46-51. 10.1086\/426443","journal-title":"Clin Infect Dis"},{"key":"ref65","article-title":"Epidemiology of group A streptococcal pharyngitis and impetigo: a cross-sectional and follow up study in a rural community of northern India","volume":"130","author":"Shah B","year":"2009","unstructured":"Shah B, Ganguly NK. Epidemiology of group A streptococcal pharyngitis and impetigo: a cross-sectional and follow up study in a rural community of northern India. Indian J Med Res. 2009, 130:765-71.","journal-title":"Indian J Med Res"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00112-12","article-title":"Variability in the distribution of genes encoding virulence factors and putative extracellular proteins of Streptococcus pyogenes in India, a region with high streptococcal disease burden, and implication for development of a regional multisubunit vaccine","volume":"19","author":"Sagar V","year":"2012","unstructured":"Sagar V, Bergmann R, Nerlich A, McMillan DJ, Nitsche Schmitz DP, Chhatwal GS. Variability in the distribution of genes encoding virulence factors and putative extracellular proteins of Streptococcus pyogenes in India, a region with high streptococcal disease burden, and implication for development of a regional multisubunit vaccine. Clin Vaccine Immunol. 2012, 19:1818-25. 10.1128\/CVI.00112-12","journal-title":"Clin Vaccine Immunol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2014.04.011","article-title":"Differences in virulence repertoire and cell invasive potential of group A streptococcus emm1-2 in comparison to emm1 genotype","volume":"304","author":"Sagar V","year":"2014","unstructured":"Sagar V, Bergmann R, Nerlich A, et al.. Differences in virulence repertoire and cell invasive potential of group A streptococcus emm1-2 in comparison to emm1 genotype. Int J Med Microbiol. 2014, 304:685-95. 10.1016\/j.ijmm.2014.04.011","journal-title":"Int J Med Microbiol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.93437","article-title":"Streptococcus pyogenes pharyngitis and impetigo in a rural area of Panchkula district in Haryana, India","volume":"135","author":"Kumar R","year":"2012","unstructured":"Kumar R, Chakraborti A, Aggarwal AK, et al.. Streptococcus pyogenes pharyngitis and impetigo in a rural area of Panchkula district in Haryana, India. Indian J Med Res. 2012, 135:133-6. 10.4103\/0971-5916.93437","journal-title":"Indian J Med Res"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.2874","article-title":"Molecular epidemiology and virulence characteristics of prevalent group A streptococci recovered from patients in northern India","volume":"8","author":"Arya DK","year":"2014","unstructured":"Arya DK, Sharma A, Mehta G, Dua M, Johri AK. Molecular epidemiology and virulence characteristics of prevalent group A streptococci recovered from patients in northern India. J Infect Dev Countries. 2014, 8:271-81. 10.3855\/jidc.2874","journal-title":"J Infect Dev Countries"},{"key":"ref70","article-title":"Current approaches to group A streptococcal vaccine development","author":"Dale JB","year":"2016","unstructured":"Dale JB, Batzloff MR, Cleary PP, et al.. Current approaches to group A streptococcal vaccine development. Streptococcus Pyogenes: Basic Biology to Clinical Manifestations [Internet]. University of Oklahoma Health Sciences Center, Oklahoma; 2016. 83-110."},{"key":"ref71","article-title":"Current knowledge of type-specific M antigens of group A streptococci","volume":"1","author":"Lancefield RC","year":"1962","unstructured":"Lancefield RC. Current knowledge of type-specific M antigens of group A streptococci. J Immunol. 1962, 1:307-13.","journal-title":"J Immunol"},{"key":"ref72","article-title":"Failure of type-specific Streptococcus pyogenes vaccine to prevent respiratory infections","volume":"46","author":"Young DC","year":"1946","unstructured":"Young DC, Breese BB, Errington AF, Stoeffler W. Failure of type-specific Streptococcus pyogenes vaccine to prevent respiratory infections. US Navy Med Bull. 1946, 46:709-18.","journal-title":"US Navy Med Bull"},{"key":"ref73","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/106.3.250","article-title":"Type-specific antibody formation in man following injection of streptococcal M protein","volume":"106","author":"Schmidt WC","year":"1960","unstructured":"Schmidt WC. Type-specific antibody formation in man following injection of streptococcal M protein. J Infect Dis. 1960, 106:250-5.","journal-title":"J Infect Dis"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1084\/jem.124.6.1135","article-title":"Antigenicity of the M proteins of group A hemolytic streptococci: III. Antibody responses and cutaneous hypersensitivity in humans","volume":"124","author":"Fox EN","year":"1966","unstructured":"Fox EN, Wittner MK, Dorfman A. Antigenicity of the M proteins of group A hemolytic streptococci: III. Antibody responses and cutaneous hypersensitivity in humans. J Exp Med. 1966, 124:1135-51. 10.1084\/jem.124.6.1135","journal-title":"J Exp Med"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1084\/jem.150.4.862","article-title":"Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein","volume":"150","author":"Beachey EH","year":"1979","unstructured":"Beachey EH, Stollerman GH, Johnson RH, Ofek I, Bisno AL. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med. 1979, 150:862-77. 10.1084\/jem.150.4.862","journal-title":"J Exp Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1084\/jem.163.6.1451","article-title":"Opsonic antibodies evoked by hybrid peptide copies of types 5 and 24 streptococcal M proteins synthesized in tandem","volume":"163","author":"Beachey EH","year":"1986","unstructured":"Beachey EH, Gras-Masse H, Tarter A, Jolivet M, Audibert F, Chedid L, Seyer JM. Opsonic antibodies evoked by hybrid peptide copies of types 5 and 24 streptococcal M proteins synthesized in tandem. J Exp Med. 1986, 163:1451-8. 10.1084\/jem.163.6.1451","journal-title":"J Exp Med"},{"key":"ref77","article-title":"Recombinant tetravalent group A streptococcal M protein vaccine","volume":"15","author":"Dale JB","year":"1993","unstructured":"Dale JB, Chiang EY, Lederer JW. Recombinant tetravalent group A streptococcal M protein vaccine. J Immunol. 1993, 15:2188-94.","journal-title":"J Immunol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00150-9","article-title":"Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments","volume":"17","author":"Dale JB","year":"1999","unstructured":"Dale JB. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Vaccine. 1999, 17:193-200. 10.1016\/S0264-410X(98)00150-9","journal-title":"Vaccine"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.6.709","article-title":"Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial","volume":"292","author":"Kotloff KL","year":"2004","unstructured":"Kotloff KL, Corretti M, Palmer K, et al.. Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial. JAMA. 2004, 292:709-15. 10.1001\/jama.292.6.709","journal-title":"JAMA"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.4.2171-2177.2002","article-title":"Immunogenicity of a 26-valent group A streptococcal vaccine","volume":"70","author":"Hu MC","year":"2002","unstructured":"Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun. 2002, 70:2171-7. 10.1128\/IAI.70.4.2171-2177.2002","journal-title":"Infect Immun"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers","volume":"41","author":"McNeil SA","year":"2005","unstructured":"McNeil SA, Halperin SA, Langley JM, et al.. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis. 2005, 41:1114-22. 10.1086\/444458","journal-title":"Clin Infect Dis"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci","volume":"29","author":"Dale JB","year":"2011","unstructured":"Dale JB, Penfound TA, Chiang EY, Walton WJ. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine. 2011, 29:8175-8. 10.1016\/j.vaccine.2011.09.005","journal-title":"Vaccine"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.12.005","article-title":"Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: a randomized, controlled phase I study","volume":"38","author":"Pastural \u00c9","year":"2020","unstructured":"Pastural \u00c9, McNeil SA, MacKinnon-Cameron D, et al.. Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: a randomized, controlled phase I study. Vaccine. 2020, 38:1384-92. 10.1016\/j.vaccine.2019.12.005","journal-title":"Vaccine"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007511","article-title":"Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease","volume":"13","author":"Giffard PM","year":"2019","unstructured":"Giffard PM, Tong SY, Holt DC, Ralph AP, Currie BJ. Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease. PLoS Negl Trop Dis. 2019, 13:e0007511. 10.1371\/journal.pntd.0007511","journal-title":"PLoS Negl Trop Dis"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.5.2734-2738.2002","article-title":"A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies","volume":"70","author":"Olive C","year":"2002","unstructured":"Olive C, Batzloff MR, Horv\u00e1th A, et al.. A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies. Infect Immun. 2002, 70:2734-8. 10.1128\/IAI.70.5.2734-2738.2002","journal-title":"Infect Immun"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1086\/374800","article-title":"Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection","volume":"187","author":"Batzloff MR","year":"2003","unstructured":"Batzloff MR, Hayman WA, Davies MR, Zeng M, Pruksakorn S, Brandt ER, Good MF. Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection. J Infect Dis. 2003, 187:1598-608. 10.1086\/374800","journal-title":"J Infect Dis"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198658","article-title":"Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial","volume":"13","author":"Sekuloski S","year":"2018","unstructured":"Sekuloski S, Batzloff MR, Griffin P, et al.. Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial. PLoS One. 2018, 13:e0198658. 10.1371\/journal.pone.0198658","journal-title":"PLoS One"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-00222-2","article-title":"M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)","volume":"5","author":"Mills JS","year":"2020","unstructured":"Mills JS, Jayashi Flores CM, Reynolds S, et al.. M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP). NPJ Vaccines. 2020, 5:74. 10.1038\/s41541-020-00222-2","journal-title":"NPJ Vaccines"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2009.03.024","article-title":"A vaccine against S. pyogenes: design and experimental immune response","volume":"49","author":"Guilherme L","year":"2009","unstructured":"Guilherme L, Postol E, Freschi de Barros S, et al.. A vaccine against S. pyogenes: design and experimental immune response. Methods. 2009, 49:316-21. 10.1016\/j.ymeth.2009.03.024","journal-title":"Methods"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46244-2","article-title":"Group A streptococcus adsorbed vaccine: repeated intramuscular dose toxicity test in minipigs","volume":"9","author":"Postol E","year":"2019","unstructured":"Postol E, S\u00e1-Rocha LC, Sampaio RO, et al.. Group A streptococcus adsorbed vaccine: repeated intramuscular dose toxicity test in minipigs. Sci Rep. 2019, 9:9733. 10.1038\/s41598-019-46244-2","journal-title":"Sci Rep"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1994.1044","article-title":"Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci","volume":"16","author":"Kapur V","year":"1994","unstructured":"Kapur V, Maffei JT, Greer RS, Li LL, Adams GJ, Musser JM. Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci. Microb Pathog. 1994, 16:443-50. 10.1006\/mpat.1994.1044","journal-title":"Microb Pathog"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00803-4","article-title":"Stimulation of long-lasting protection against Streptococcus pyogenes after intranasal vaccination with non adjuvanted fibronectin-binding domain of the SfbI protein","volume":"21","author":"Schulze K","year":"2003","unstructured":"Schulze K, Medina E, Chhatwal GS, Guzm\u00e1n CA. Stimulation of long-lasting protection against Streptococcus pyogenes after intranasal vaccination with non adjuvanted fibronectin-binding domain of the SfbI protein. Vaccine. 2003, 21:1958-64. 10.1016\/S0264-410X(02)00803-4","journal-title":"Vaccine"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.12.7342-7345.2004","article-title":"Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination of Streptococcus pyogenes in a murine skin infection model","volume":"72","author":"McArthur J","year":"2004","unstructured":"McArthur J, Medina E, Mueller A, et al.. Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination of Streptococcus pyogenes in a murine skin infection model. Infect Immun. 2004, 72:7342-5. 10.1128\/IAI.72.12.7342-7345.2004","journal-title":"Infect Immun"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.11.031","article-title":"Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein\/SfbI lipid core peptide vaccine formulation","volume":"25","author":"Olive C","year":"2007","unstructured":"Olive C, Schulze K, Sun HK, Ebensen T, Horv\u00e1th A, Toth I, Guzman CA. Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein\/SfbI lipid core peptide vaccine formulation. Vaccine. 2007, 25:1789-97. 10.1016\/j.vaccine.2006.11.031","journal-title":"Vaccine"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.2.924-930.2001","article-title":"Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice","volume":"69","author":"Kawabata S","year":"2001","unstructured":"Kawabata S, Kunitomo E, Terao Y, Nakagawa I, Kikuchi K, Totsuka K, Hamada S. Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice. Infect Immun. 2001, 69:924-30. 10.1128\/IAI.69.2.924-930.2001","journal-title":"Infect Immun"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix599","article-title":"Immune cross-opsonization within emm clusters following group A streptococcus skin infection: broadening the scope of type-specific immunity","volume":"65","author":"Frost HR","year":"2017","unstructured":"Frost HR, Laho D, Sanderson-Smith ML, et al.. Immune cross-opsonization within emm clusters following group A streptococcus skin infection: broadening the scope of type-specific immunity. Clin Infect Dis. 2017, 65:1523-31. 10.1093\/cid\/cix599","journal-title":"Clin Infect Dis"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.11.065","article-title":"Structure-based design of broadly protective group a streptococcal M protein-based vaccines","volume":"35","author":"Dale JB","year":"2017","unstructured":"Dale JB, Smeesters PR, Courtney HS, Penfound TA, Hohn CM, Smith JC, Baudry JY. Structure-based design of broadly protective group a streptococcal M protein-based vaccines. Vaccine. 2017, 35:19-26. 10.1016\/j.vaccine.2016.11.065","journal-title":"Vaccine"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1086\/498618","article-title":"Group A streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection","volume":"193","author":"Sabharwal H","year":"2006","unstructured":"Sabharwal H, Michon F, Nelson D, et al.. Group A streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection. J Infect Dis. 2006, 193:129-35. 10.1086\/498618","journal-title":"J Infect Dis"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00618-16","article-title":"Differing efficacies of lead group A streptococcal vaccine candidates and full-length M protein in cutaneous and invasive disease models","volume":"7","author":"Rivera-Hernandez T","year":"2016","unstructured":"Rivera-Hernandez T, Pandey M, Henningham A, et al.. Differing efficacies of lead group A streptococcal vaccine candidates and full-length M protein in cutaneous and invasive disease models. MBio. 2016, 7:e00618-16. 10.1128\/mBio.00618-16","journal-title":"MBio"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00693-19","article-title":"An experimental group A streptococcus vaccine that reduces pharyngitis and tonsillitis in a nonhuman primate model","volume":"10","author":"Rivera-Hernandez T","year":"2019","unstructured":"Rivera-Hernandez T, Carnathan DG, Jones S, et al.. An experimental group A streptococcus vaccine that reduces pharyngitis and tonsillitis in a nonhuman primate model. MBio. 2019, 10:693-719. 10.1128\/mBio.00693-19","journal-title":"MBio"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.06.042","article-title":"Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi","volume":"27","author":"Turner CE","year":"2009","unstructured":"Turner CE, Kurupati P, Wiles S, Edwards RJ, Sriskandan S. Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi. Vaccine. 2009, 27:4923-9. 10.1016\/j.vaccine.2009.06.042","journal-title":"Vaccine"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501994","article-title":"Combinatorial synthetic peptide vaccine strategy protects against hypervirulent CovR\/S mutant streptococci","volume":"196","author":"Pandey M","year":"2016","unstructured":"Pandey M, Mortensen R, Calcutt A, Powell J, Batzloff MR, Dietrich J, Good MF. Combinatorial synthetic peptide vaccine strategy protects against hypervirulent CovR\/S mutant streptococci. J Immunol. 2016, 196:3364-74. 10.4049\/jimmunol.1501994","journal-title":"J Immunol"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1038\/74719","article-title":"New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population","volume":"6","author":"Brandt ER","year":"2000","unstructured":"Brandt ER, Sriprakash KS, Hobb RI, et al.. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat Med. 2000, 6:455-9. 10.1038\/74719","journal-title":"Nat Med"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.4161\/hv.20654","article-title":"Pneumococcal conjugate vaccine: a newer vaccine available in India","volume":"8","author":"Verma R","year":"2012","unstructured":"Verma R, Khanna P. Pneumococcal conjugate vaccine: a newer vaccine available in India. Hum Vaccines Immunother. 2012, 8:1317-20. 10.4161\/hv.20654","journal-title":"Hum Vaccines Immunother"},{"key":"ref105","article-title":"Rheumatic fever and rheumatic heart disease: the last 50 years","volume":"137","author":"Kumar RK","year":"2013","unstructured":"Kumar RK, Tandon R. Rheumatic fever and rheumatic heart disease: the last 50 years. Indian J Med Res. 2013, 137:643.","journal-title":"Indian J Med Res"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112344","article-title":"The dynamics of streptococcal infections in a defined population of children: serotypes associated with skin and respiratory infections","volume":"104","author":"Anthony BF","year":"1976","unstructured":"Anthony BF, Kaplan EL, Wannamaker LW, Chapman SS. The dynamics of streptococcal infections in a defined population of children: serotypes associated with skin and respiratory infections. Am J Epidemiol. 1976, 104:652-66. 10.1093\/oxfordjournals.aje.a112344","journal-title":"Am J Epidemiol"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2014.05.008","article-title":"Immune response against M protein-conserved region peptides from prevalent group A streptococcus in a north Indian population","volume":"49","author":"Gupta VK","year":"2016","unstructured":"Gupta VK, Sekhar S, Dhanda V, Toor D, Kumar R, Chakraborti A. Immune response against M protein-conserved region peptides from prevalent group A streptococcus in a north Indian population. J Microbiol Immunol Infect. 2016, 49:352-8. 10.1016\/j.jmii.2014.05.008","journal-title":"J Microbiol Immunol Infect"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1021\/pr3005265","article-title":"Identification of potential universal vaccine candidates against group A streptococcus by using high throughput in silico and proteomics approach","volume":"12","author":"Sharma A","year":"2013","unstructured":"Sharma A, Arya DK, Sagar V, Bergmann R, Chhatwal GS, Johri AK. Identification of potential universal vaccine candidates against group A streptococcus by using high throughput in silico and proteomics approach. J Proteome Res. 2013, 12:336-46. 10.1021\/pr3005265","journal-title":"J Proteome Res"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17299-x","article-title":"Cross-serotype protection against group A streptococcal infections induced by immunization with SPy_2191","volume":"11","author":"Sanduja P","year":"2020","unstructured":"Sanduja P, Gupta M, Somani VK, et al.. Cross-serotype protection against group A streptococcal infections induced by immunization with SPy_2191. Nat Commun. 2020, 11:3545. 10.1038\/s41467-020-17299-x","journal-title":"Nat Commun"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1007\/BF01964407","article-title":"The resurgence of group A streptococcal infections and their sequelae","volume":"10","author":"Kaplan EL","year":"1991","unstructured":"Kaplan EL. The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis. 1991, 10:55-7. 10.1007\/BF01964407","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/89141-group-a-streptococcus-infections-their-mechanisms-epidemiology-and-current-scope-of-vaccines","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:55Z","timestamp":1707508015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/89141-group-a-streptococcus-infections-their-mechanisms-epidemiology-and-current-scope-of-vaccines"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":110,"URL":"https:\/\/doi.org\/10.7759\/cureus.33146","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}